Redwood City, CA, United States of America

Renu Jain

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Renu Jain. Retrieved from https://idiyas.com/inventor/renu-jain-8ci4xdiw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Renu Jain: Innovator in Cancer Treatment

Introduction

Renu Jain is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development efforts.

Latest Patents

Renu Jain holds a patent for "Anti-CCR8 Antibodies for Treating Cancer." This patent represents her commitment to advancing medical science and improving treatment options for cancer patients. She has 1 patent to her name, showcasing her dedication to innovation in healthcare.

Career Highlights

Renu Jain is currently employed at Bristol-Myers Squibb Company, a leading biopharmaceutical company known for its focus on discovering, developing, and delivering innovative medicines. Her work at Bristol-Myers Squibb has positioned her as a key player in the fight against cancer.

Collaborations

Throughout her career, Renu has collaborated with talented professionals, including Ruth Yin-Zong Lan and Olufemi A. Adelakun. These collaborations have further enhanced her research and contributed to the development of groundbreaking treatments.

Conclusion

Renu Jain's contributions to cancer treatment through her patent and work at Bristol-Myers Squibb highlight her role as an influential inventor in the medical field. Her dedication to innovation continues to inspire advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…